| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
70,463 |
66,071 |
$3.69M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
39,587 |
37,397 |
$2.83M |
| X5622 |
|
20,780 |
19,392 |
$1.79M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
22,474 |
22,074 |
$1.48M |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
64,845 |
61,809 |
$1.46M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
25,693 |
22,919 |
$1.29M |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
29,382 |
25,629 |
$1.14M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
14,044 |
13,774 |
$877K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
23,605 |
23,013 |
$752K |
| 59400 |
Routine obstetric care including antepartum care, vaginal delivery, and postpartum care |
728 |
710 |
$649K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
31,145 |
30,193 |
$481K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
12,732 |
5,522 |
$470K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
20,337 |
19,742 |
$382K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
8,137 |
5,325 |
$366K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,521 |
4,416 |
$295K |
| 99188 |
|
31,031 |
30,444 |
$240K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
5,651 |
3,465 |
$222K |
| 92551 |
|
28,925 |
28,338 |
$162K |
| 96127 |
|
42,007 |
41,130 |
$144K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
1,153 |
1,139 |
$138K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,967 |
1,916 |
$121K |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
2,209 |
2,131 |
$121K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14,325 |
13,072 |
$101K |
| 99215 |
Prolong outpt/office vis |
877 |
838 |
$94K |
| 99243 |
|
1,069 |
1,053 |
$91K |
| 76830 |
Ultrasound, transvaginal |
1,894 |
1,135 |
$86K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
1,857 |
1,825 |
$83K |
| 90715 |
|
4,028 |
3,848 |
$80K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,373 |
2,211 |
$69K |
| 97803 |
|
1,781 |
1,690 |
$66K |
| 90834 |
Psychotherapy, 45 minutes with patient |
920 |
576 |
$62K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
898 |
870 |
$61K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
576 |
566 |
$61K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,181 |
956 |
$58K |
| 59425 |
|
165 |
154 |
$58K |
| 90686 |
|
24,251 |
23,774 |
$54K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
66 |
64 |
$44K |
| 76801 |
|
874 |
532 |
$42K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,396 |
656 |
$37K |
| 59510 |
|
43 |
40 |
$36K |
| 91322 |
|
354 |
351 |
$33K |
| 99173 |
|
27,443 |
26,944 |
$32K |
| 71046 |
Radiologic examination, chest; 2 views |
1,985 |
1,680 |
$31K |
| 90480 |
|
1,055 |
1,025 |
$31K |
| 90473 |
|
2,626 |
2,492 |
$31K |
| 96161 |
|
17,403 |
16,581 |
$28K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
713 |
636 |
$27K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,423 |
1,688 |
$26K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
381 |
364 |
$23K |
| 59025 |
Fetal non-stress test |
668 |
400 |
$20K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
299 |
275 |
$19K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
437 |
247 |
$19K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
585 |
522 |
$19K |
| 90651 |
|
1,764 |
1,717 |
$18K |
| 0072A |
|
388 |
388 |
$16K |
| 94010 |
|
950 |
922 |
$15K |
| 99245 |
|
102 |
101 |
$14K |
| 97802 |
|
197 |
196 |
$13K |
| 76818 |
|
206 |
114 |
$13K |
| 58300 |
|
202 |
192 |
$13K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
24 |
24 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
504 |
478 |
$12K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
498 |
472 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
741 |
568 |
$11K |
| 74018 |
|
695 |
664 |
$11K |
| 0071A |
|
242 |
235 |
$10K |
| 0002A |
|
238 |
237 |
$10K |
| 99417 |
Prolong home eval add 15m |
155 |
153 |
$9K |
| 96040 |
|
163 |
159 |
$7K |
| 90677 |
|
2,248 |
2,177 |
$7K |
| 0001A |
|
143 |
142 |
$6K |
| 76857 |
|
306 |
180 |
$5K |
| 87480 |
|
437 |
409 |
$5K |
| 87510 |
|
437 |
409 |
$5K |
| 87660 |
|
437 |
409 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
444 |
429 |
$5K |
| 99383 |
|
58 |
57 |
$5K |
| 90656 |
|
1,814 |
1,804 |
$5K |
| 99382 |
|
53 |
50 |
$4K |
| 0052A |
|
97 |
97 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
2,145 |
1,863 |
$4K |
| 86780 |
|
330 |
322 |
$3K |
| 90694 |
|
56 |
56 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
152 |
118 |
$3K |
| 77080 |
|
154 |
152 |
$3K |
| 99242 |
|
42 |
41 |
$3K |
| G0008 |
Administration of influenza virus vaccine |
313 |
313 |
$3K |
| 59514 |
|
31 |
29 |
$2K |
| 83655 |
|
301 |
293 |
$2K |
| 87070 |
|
343 |
332 |
$2K |
| 90653 |
|
24 |
24 |
$2K |
| 0081A |
|
50 |
49 |
$2K |
| 58301 |
|
25 |
25 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
227 |
196 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
291 |
275 |
$2K |
| 59430 |
|
16 |
12 |
$2K |
| 11981 |
|
39 |
37 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
15 |
15 |
$2K |
| 87150 |
|
42 |
40 |
$1K |
| 96380 |
|
90 |
85 |
$1K |
| 85018 |
|
694 |
678 |
$1K |
| A4627 |
Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler |
57 |
56 |
$1K |
| 11982 |
|
12 |
12 |
$1K |
| 91321 |
|
329 |
319 |
$992.49 |
| 90670 |
|
12,959 |
12,553 |
$933.04 |
| 90620 |
|
77 |
75 |
$906.94 |
| 94060 |
|
54 |
52 |
$875.76 |
| 36416 |
|
428 |
404 |
$686.48 |
| 84443 |
Thyroid stimulating hormone (TSH) |
57 |
56 |
$656.73 |
| 98968 |
|
23 |
13 |
$605.46 |
| 90707 |
|
1,352 |
1,270 |
$558.85 |
| 0051A |
|
13 |
13 |
$530.50 |
| 82950 |
|
129 |
128 |
$497.11 |
| 0124A |
|
12 |
12 |
$448.71 |
| 69210 |
|
12 |
12 |
$412.71 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
15 |
12 |
$390.62 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
44 |
43 |
$367.22 |
| 69209 |
|
27 |
26 |
$345.75 |
| H1000 |
Prenatal care, at-risk assessment |
69 |
67 |
$340.52 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$285.36 |
| 84702 |
|
18 |
12 |
$267.48 |
| 90681 |
|
5,642 |
5,377 |
$239.84 |
| 90723 |
|
11,301 |
10,870 |
$230.56 |
| 85027 |
|
24 |
24 |
$162.09 |
| 81001 |
|
46 |
44 |
$162.07 |
| 90716 |
|
1,819 |
1,733 |
$132.88 |
| 90734 |
|
1,277 |
1,240 |
$126.51 |
| 86850 |
|
12 |
12 |
$106.37 |
| 90647 |
|
10,638 |
10,268 |
$87.58 |
| 90633 |
|
5,739 |
5,572 |
$67.78 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
254 |
242 |
$17.19 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
20 |
12 |
$14.14 |
| 90696 |
|
1,105 |
1,084 |
$0.27 |
| 90700 |
|
1,347 |
1,320 |
$0.24 |
| 90710 |
|
866 |
850 |
$0.24 |
| 90381 |
|
45 |
42 |
$0.00 |
| 88142 |
|
63 |
58 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
14 |
12 |
$0.00 |
| 95117 |
|
25 |
12 |
$0.00 |
| 87430 |
|
49 |
45 |
$0.00 |
| 90685 |
|
1,717 |
1,665 |
$0.00 |
| 90672 |
|
35 |
35 |
$0.00 |
| 90713 |
|
28 |
28 |
$0.00 |
| 17110 |
|
12 |
12 |
$0.00 |